Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Benk - Any news on shareholder meeting?
>> What is so hard to accept about a tentative plan to have an AGM toward the end of Q1, to be made official (I imagine) sometime after the beginning of the new year? Does your crystal ball tell you that January will pass without such an announcement? So why stir up agitation about it now?
If it will make you happier to hear that I - and I think others would echo this sentiment - will express disappointment to management if nothing is scheduled during January, OK, I'll go on record. OK? Feeling better? Great!
Waterdog - Do you have an update to your timeline regarding initial sales, hospital testing etc..? This is what you were expecting in December
>> IMO, I expect to see a few of THESE initial AsepticSure units in the field before the end of January...how MANY units, I don't know,
>> but I'd guess at least a handfull. Before the first USA hospital beta trial, which Ed said would happen early in 2011, we likely will have
>> several larger units already in operation throughout certain parts of the world.
Benk - Or perhaps it's clear that most of the investing public doesn't have the same confidence in management's ability to CAPITALIZE on all this incredible potential as you do.
>> It's clear that this bizarre reality is more about the intrinsic nature of the OTC,
So that begs the questions, why is it still .15 cents? There are thousands of money tv viewers. There are thousands of employees of the hospital where the testing was done. Why aren't they investing? The argument that when people will find out about it they will invest has been disproven by these groups that aren't investing!!
>> I think that many people out there can do enough math to figure out that MZEI is worth a heck of a lot more than .15 a share.
"The next phase of beta testing will begin in early 2011 "
This is from the 12/17/2010 Update
Anyone know if this has started and if not what is the delay?
The part that I disagree with is that is not only damaging short-term. Long-term, in order for this share price to get were we think it deserves to be will take significant investment by the broader investing community. Sales and revenue don't automaically equate to value. There are many companies with billions of $'s in sales that lose money. If investors don't have confidence in management, even announcements of sales will not get this stock to it's appropriate level. Part of building confidence is showing you know what investors expect and delivering on it. I think investors expect clear communications, a clearly defined business model, a management team with experience in running a product producing company on a daily basis etc.. So far that has been lacking, partially due to a lack of funding. Hopefully this will change in the near future.
>> As I have said many times, and will continue to say, the lack of savvy in communications is annoying, and damaging to the short-term >> interests of the Company
Wouldn't it have made sense for the company to have been proactive in putting out some explanation for the selling? They should have been smart enough to know that this could very possible be construed in a negative light. In my mind it's an example of management seemingly "not getting it" when it comes to expected communication from a professionally run public company.
I don't doubt he is very optimistic, as am I. I wish I could justify increasing my position, but can't right now. That being said it still doesn't look great for him to be selling now and it certainly is a reach to make it into a positive. You are allowed to optimistic about an investment without spinning everything into good news!
The optimism or spin on this board strains credibility. Why would the person the most in the know depart with 15% of his holdings if such big news was imminent?
These were his personal shares, not Medizone raising money to continue testing.
I disagree - if they are ready for sales, this information should be readily available to all. It speaks to the lack of business operations information that would give confidence to prospective shareholders that this company, as currently constituted, can make good on their tremendous potential.
According to a news update late last year Medizone is ready to accept orders. I'm familiar with the principals of a large food industry manufacturer on the East coast. Assuming they are interested in Asepticsure these are some of the questions they have:
How much does it cost for a 200,000 square foot production area?
Are there leasing options?
How long will one of these machines last?
How much maintenance is needed?
Who will be able to provide such maintenance?
Will there be a local East coast office/sales contact that will deal with issues?
Are they warranted?
etc, etc...
Unfortunately I have yet to see a single piece of information that deals with these questions.
I am optimistc for someone whose been around for 11+ years :)
I'm tired of:
Missed timelines with no solid explanations - e.g gov't news by end of year
Cheerleading by certain board members - I won't name names :)
Derision aimed at anyone who dares to raise some valid points if they aren't lockstep with management e.g whatisvalue.
I'm disappointed that the main focus of the company has shifted from hospital sterilization. The initial timeline of a couple weeks hospital testing and then on to production was never realistic. There was no way they could prove reduced HAI in such a short time-frame. Now management acknowledges that, but never takes responsibility for the widely optimistic or naive projections.
Otherwise I'm a happy camper :) I still believe that there is great potential here that can be realized.
I think you are all making much ado about nothing, or grasping for some positive info - all that happened was that the patent was published.
The priority date was 07/2009 so 18 months later is 01/2011. All it means is that it is now public, nothing more - doesn't mean the patent was granted.
Let's hope for some real news, though given Mr. Marshall's track record of meeting timelines I'm rather skeptical we will hear anything noteworth mid-January.
http://en.wikipedia.org/wiki/Patent_application
Patent applications are generally published 18 months after the earliest priority date of the application. Prior to that publication the application is confidential to the patent office. After publication, depending upon local rules, certain parts of the application file may remain confidential, but it is common for all communications between an Applicant (or his agent) and the patent office to be publicly available.
In the last MoneyTV interview Ed mentioned more information regarding government involvement would be disclosed by the end of the year. Is there an explnation for the delay?
This was "published" over a year ago!
Biodefense
Potent new biodefense technology shows promise
Published 2 December 2009
Benk - It sounds as if there is no need for new technology to prevent most of these infections!
>> But research shows that nearly all the infections are preventable when safety measures are used consistently by hospital staff.
WD - What could stop us is competition. I know everyone preaches patience but with $60billion spent annually on pharmaceutical/biotechnology R&D in the US alone, isn't it possible there is someone out there also developing a solution to this problem that you are't aware of? My experience is that there is no such thing as absolutely, until it actually happens
>> There is absolutely nothing that can hinder this; nothing that can >>derail this; and absolutely NOTHING that can stop it.
BenK - I think the market might have been more impressed if they could have gotten some more information as to who Mammoth is. Their website is unimpressive for an "investment bank". There is no mention of any of the principals involved in this outfit. Very strange to me.
Was I the only old-timer who noticed the coincidence that the $ amount ($10 million) is what Groundell was promising? Of course that was at $5/share, not 20 cents!!
>>At the same time he is disappointed (understatement) and baffled that this news did not evoke a stronger response from the market.
Goforbet quoted the "Stock Loan" link. It looks like this deal would better be described under their "PIPES" link:
Mammoth Corporation can structure an equity line or PIPE transaction to meet the needs of a prospective issuer to specifically complement a company’s situation. Typically, Mammoth provides a firm commitment to purchase an agreed upon dollar amount of an issuer’s shares over a specified period of time. The time frame of this commitment can be as short as desired or as far out as 24 months.
Unlike some, Mammoth Corporation does not pre-sell or short a position. The mechanics of the Equity Line provide a sufficient return versus the risk that Mammoth Corporation accepts. Some who claim to purchase shares at 90% to 100% of prevailing bid prices and some who offer convertible debenture PIPEs rely on riskless transactions of selling stock and sometimes earning profits both through a short position and through the issuance of stock pursuant to bottomless instruments. Asking how an investor is going to profit is key to assessing the merit of a proposed transaction. Deals that appear favorable at first glance, but rely instead on pre-selling or shorting the shares can decimate a company’s market. Mammoth Corporation accepts risk in its transactions and seeks to profit over an extended period of time through controlled selling seeking to diminish the impact of the sales. The terms of Mammoth Corporation’s PIPEs make clear the risk Mammoth Corporation is willing to accept. The issuer decides when and if to sell shares to Mammoth Corporation under the terms of the pipe. The fair discount Mammoth Corporation receives is how Mammoth Corporation earns its profit, not by shorting or pre-selling shares. If the stock price goes down, Mammoth Corporation loses money.
These types of financial vehicles are designed with flexibility and control for the issuer in mind. The issuer can sell to Mammoth as little or as much as needed at points in time of their choosing, subject to reasonable limitations spelled out in the agreement. This type of control an issuer has over his shares is one of the key attributes that set this vehicle apart from more traditional debt or convertible alternatives. Key Points:
Issuer has right to sell to shares to Mammoth (similar to a put option)
Timing and amount of shares at issuer’s discretion, eliminating overhang
Issuer has complete control over stock’s dilution
Issuer not obligated to sell any shares
References Available
Thanks for the clarification - I didn't realize that private placements were discounted.
I'm confused - until now we were raising money from investors at market value and we were told funding is not an issue. Now we are raising it at a 25% discount and this is good news?
If your conjecture is correct, that would preclude testing results that show a lower incidence of HAI's by using Asepticsure. In order to do that a hospital would have to admit that a specific number of instances of HAI's occurred before Asepticsure.
I still think that that is the "Big" news we are waiting for. The big yawn the market gave to last weeks announcement certainly seems to indicate we are waiting for more proof.
BenK - Were you able to get any clarification on these questions?
1. What exactly are we trying to prove with the current BETA testing?
2. What is the time-frame for these tests to be completed?
3. Does management feel that it is necessary to prove reduced HAI's before hospitals are willing to buy this product?
I'm also curious why we needed to use "Pre-inoculated stainless steel test discs" if these spaces are already full of these contaminents?
Thanks in advance
BenK - You seem to be a voice of reason on this board and seem to have a good rapport with management. Perhaps you can get some clarification regarding testing protocols and time-frames.
In a PR on 08/09/2009 management projected initial sales to commence 2 months after hospital beta testing started - that certainly doesn't seem to indicate that they expected to prove a lower incidence of HAI's before they would be able to sell Asepticsure. Can you possible get some clarification:
1. What exactly are we trying to prove with the current BETA testing?
2. What is the time-frame for these tests to be completed?
3. Does management feel that it is necessary to prove reduced HAI's before hospitals are willing to buy this product?
It seems our testing partner requires some more convincing before jumping in and from the low volume of the last week it is obvious the "market" expects to see more before investing in MZEI.
No I've never heard that they plan to do a whole wing. That would be great. Is there a time frame for how long that will take?
Yes - plenty of DD, Almost 12 years worth. There is a huge jump from disinfecting objects in a room to reducing HAIs.
I have no idea how HAIs are spread. Are they planning on Asepticsuring every person and object as they enter the hospital?
I fail to see the Huge news. I thought that the testing was going to prove that we were able to reduce HAIs and save hospitals $6-7 for each $1 spent. All this last test proved is that we can disinfect objects in a room and that Dr. Shanonn wasn't making up the previous released test results.
Until we prove that by using this technology there will be fewer HAIs I don't see that there is anything to sell (at least as far as hospitals; food, bed bugs etc might be a different story). That proof seems months away, and to this 12+ years investor, that is disappointing!! Considering the volume, share price it seems I'm not the only one with this sentiment.
BenK The market seems to disagree :(
until we prove that we reduce HAI's there is no compelling cost-saving selling point. For all we know HAI's are not acquired from unsterile operating surfaces. Maybe patients get them from visitors, unclean dr. hands etc..
It is worth noting that this hospital did not say that we need to start using this technology right away, just that it "APPEARS to be a promising breakthrough". Had they been as excited as everyone here, I would have expected to hear "while not completely tested we must start using this now to save lives". If this hospital isn't yet interested, why do we think sales are imminent?
>> To show the long-term reduction in HAI's takes time, probably >>4-6 months IMO. But it doesn't take much imagination to project the results .
It hasn't been proven that they reduced the numbers of HAI's that a hospital typically experiences. I'm hoping that will be the next step.
It seems as if he replies to certain shareholder's e-mails and not others. I sent an e-mail almost 3 weeks ago and haven't received a response, while numerous shareholders have reported on this board getting same-day answers
Not everyone gets responses to their e-mails. I sent an e-mail 10 days ago asking for some clarification on the upcoming hospital testing and didn't receive a reply
Long time holder - since the late '90's and very excited about what is going on.
Does anyone have details on the methodology of the upcoming hospital testing? I see two possible methods and was curious if someone had spoken to Ed or Dr. Shannon about this.Is it going to be similar to the lab testing - making sure that infected areas are sanitized. Or are they hoping to prove that by using Asepticsure a hospital will go from 5 cases of MRSA/month to say 0-1/month.